Posted on May 13, 2016






ciprofloxacin gallstones

Q&A 264 - Polycystic Kidney Disease, Hemorrhoids, Gallbladder Stones, Fatter Liver, Leaky Gut ciprofloxacin gallstones.

The current study determined the spectrum of biliary microflora with special emphasis on enteric fever organisms in patients with acutecholangitis with and without cholelithiasis or other biliary diseases. The patients were divided into three groups: Group A consisted of patientswith acute cholecystitis with cholelithiasis; Group B consisted of patients with acute cholecystitis with gastrointestinal ailments requiringbiliary drainage and group C consisted of patients with gallbladder carcinoma. Gallbladder, bile and gallstones were subjected to completemicrobiological and histopathological examination. Antimicrobial susceptibility of the isolates was performed as per CLSI guidelines. Bacteriawere recovered from 17 samples (32%) in Group A, 17 (51.4%) in Group B and 1 (1.6%) in Group C. The most common organisms isolated wereEscherichia coli (11, 29.7%), Klebsiella pneumoniae (10, 27%), Citrobacter freundii (3, 8.1%), Salmonella enterica serovar Typhi (3, 8.1%), etc.The majority of Enterobacteriaceae isolates were susceptible to piperacillin-tazobactam and meropenem. As regards Salmonella spp., S. Typhiwas isolated from 2 (3.8%) patients in Group A and 1 (16%) in Group C. Antimicrobial susceptibility of potential causative organisms, theseverity of the cholecystitis, and the local susceptibility pattern must be taken into consideration when prescribing drugs. A protocol regardingthe management of such cases should be formulated based on observations of similar studies. Ciprofloxacin gallstones.

11. Csendes A., Mitru N., Maluenda F., et al. Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones orcommon bile duct stones with or without acute cholangitis. Hepatogastroenterol 1996;43:800-6.        [ Links ]



Ciprofloxacin gallstones - readmore